Brugada syndrome: report of the second consensus conference.

Since its introduction as a clinical entity in 1992, the Brugada syndrome has progressed from being a rare disease to one that is second only to automobile accidents as a cause of death among young adults in some countries. Electrocardiographically characterized by a distinct ST-segment elevation in the right precordial leads, the syndrome is associated with a high risk for sudden cardiac death in young and otherwise healthy adults, and less frequently in infants and children. Patients with a spontaneously appearing Brugada ECG have a high risk for sudden arrhythmic death secondary to ventricular tachycardia/fibrillation. The ECG manifestations of Brugada syndrome are often dynamic or concealed and may be unmasked or modulated by sodium channel blockers, a febrile state, vagotonic agents, alpha-adrenergic agonists, beta-adrenergic blockers, tricyclic or tetracyclic antidepressants, a combination of glucose and insulin, hypo- and hyperkalemia, hypercalcemia, and alcohol and cocaine toxicity. In recent years, an exponential rise in the number of reported cases and a striking proliferation of articles defining the clinical, genetic, cellular, ionic, and molecular aspects of the disease have occurred. The report of the first consensus conference, published in 2002, focused on diagnostic criteria. The present report, which emanated from the second consensus conference held in September 2003, elaborates further on the diagnostic criteria and examines risk stratification schemes and device and pharmacological approaches to therapy on the basis of the available clinical and basic science data.

[1]  A. Wilde,et al.  Genotype–Phenotype Relationship in the Brugada Syndrome , 2007 .

[2]  Charles Antzelevitch Brugada syndrome. , 2006, Pacing and clinical electrophysiology : PACE.

[3]  Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. , 2004, European heart journal.

[4]  J. Fish,et al.  Role of sodium and calcium channel block in unmasking the Brugada syndrome. , 2004, Heart rhythm.

[5]  Akira Fujiki,et al.  Vagal Activity Modulates Spontaneous Augmentation of ST Elevation in the Daily Life of Patients with Brugada Syndrome , 2004, Journal of cardiovascular electrophysiology.

[6]  Antoine Leenhardt,et al.  Hydroquinidine therapy in Brugada syndrome. , 2004, Journal of the American College of Cardiology.

[7]  H. Morita,et al.  Sinus node function in patients with Brugada-type ECG. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[8]  A. Wilde,et al.  Delay in Right Ventricular Activation Contributes to Brugada Syndrome , 2004, Circulation.

[9]  J. Kawabe,et al.  A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill , 2004, Journal of internal medicine.

[10]  A. Wear CIRCULATION , 1964, The Lancet.

[11]  J. Brugada,et al.  Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest , 2003, Circulation.

[12]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[13]  R. Asinger,et al.  ST-segment elevation in conditions other than acute myocardial infarction. , 2003, The New England journal of medicine.

[14]  P. Rizzon,et al.  QT-interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome. , 2003, Journal of the American College of Cardiology.

[15]  C. Antzelevitch Molecular Genetics of Arrhythmias and Cardiovascular Conditions Associated with Arrhythmias , 2003, Journal of cardiovascular electrophysiology.

[16]  H. Horigome,et al.  Ventricular fibrillation during anesthesia in association with J waves in the left precordial leads in a child with coarctation of the aorta. , 2003, Journal of electrocardiology.

[17]  D. Glancy,et al.  Prevalence of the Brugada electrocardiographic pattern at the Medical Center of Louisiana in New Orleans. , 2003, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

[18]  Prashanthan Sanders,et al.  Mapping and Ablation of Ventricular Fibrillation Associated With Long-QT and Brugada Syndromes , 2003, Circulation.

[19]  M. Glikson,et al.  Cardiac resynchronization therapy: a new frontier in the management of heart failure. , 2003, The Israel Medical Association journal : IMAJ.

[20]  G. Breithardt,et al.  Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: Different incidences in familial and sporadic disease , 2003, Human mutation.

[21]  G. Breithardt,et al.  The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. , 2003, European heart journal.

[22]  S. Viskin Inducible Ventricular Fibrillation in the Brugada Syndrome: , 2003, Journal of cardiovascular electrophysiology.

[23]  H. Morita,et al.  Risk stratification for asymptomatic patients with Brugada syndrome. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[24]  H. Tan,et al.  Genetic control of sodium channel function. , 2003, Cardiovascular research.

[25]  Lucas J Herfst,et al.  Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System , 2003, Circulation research.

[26]  W. Shimizu,et al.  Prominent J Wave and ST Segment Elevation: , 2003, Journal of cardiovascular electrophysiology.

[27]  J. Daubert,et al.  Novel Brugada SCN5A Mutation Leading to ST Segment Elevation in the Inferior or the Right Precordial Leads , 2003, Journal of cardiovascular electrophysiology.

[28]  K. Aonuma,et al.  Enhancement of J–ST‐Segment Elevation by the Glucose and Insulin Test in Brugada Syndrome , 2003, Pacing and clinical electrophysiology : PACE.

[29]  S. Priori,et al.  Flecainide Test in Brugada Syndrome: A Reproducible but Risky Tool , 2003, Pacing and clinical electrophysiology : PACE.

[30]  I. Gussak Cardiac repolarization : bridging basic and clinical science , 2003 .

[31]  M. Shimizu,et al.  Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[32]  S. Ogawa,et al.  New ECG criteria for high-risk Brugada syndrome. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[33]  J. Brugada,et al.  Brugada syndrome: a decade of progress. , 2002, Circulation research.

[34]  W. Shimizu,et al.  ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome. , 2002, Journal of the American College of Cardiology.

[35]  R. Hauer,et al.  Proposed diagnostic criteria for the Brugada syndrome: consensus report. , 2002, Circulation.

[36]  J. Sanderson,et al.  Brugada Syndrome Unmasked By Febrile Illness , 2002, Pacing and clinical electrophysiology : PACE.

[37]  J. Bénézet,et al.  Transient Brugada-type electrocardiographic abnormalities in renal failure reversed by dialysis. , 2002, Resuscitation.

[38]  J. Brugada,et al.  Fever Unmasking the Brugada Syndrome , 2002, Pacing and clinical electrophysiology : PACE.

[39]  Proposed diagnostic criteria for the Brugada syndrome. , 2002, European heart journal.

[40]  S. Viskin,et al.  The Brugada Syndrome: Is an Implantable Cardioverter Defibrillator the Only Therapeutic Option? , 2002, Pacing and clinical electrophysiology : PACE.

[41]  H. Morita,et al.  Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. , 2002, Journal of the American College of Cardiology.

[42]  A. Perel,et al.  ST‐Segment Deviation Following Implantable Cardioverter Defibrillator Shocks: Incidence, Timing, and Clinical Significance , 2002, Pacing and clinical electrophysiology : PACE.

[43]  P. Brugada,et al.  Heart Transplantation as Last Resort Against Brugada Syndrome , 2002, Journal of cardiovascular electrophysiology.

[44]  G. Breithardt,et al.  Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. , 2002, European heart journal.

[45]  J. Hurst,et al.  Tricyclic antidepressants and the brugada syndrome: An example of brugada waves appearing after the administration of desipramine , 2002, Clinical cardiology.

[46]  G. Breithardt,et al.  Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. , 2002, Journal of the American College of Cardiology.

[47]  M. Arita,et al.  Prevention of Ventricular Fibrillation by Cilostazol, an Oral Phosphodiesterase Inhibitor, in a Patient with Brugada Syndrome , 2002, Journal of cardiovascular electrophysiology.

[48]  H. Morita,et al.  Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. , 2002, Journal of the American College of Cardiology.

[49]  W. Shimizu,et al.  Electrophysiologic characteristics andimplications of induced ventricular fibrillationin symptomatic patients with brugada syndrome , 2002 .

[50]  C. Antzelevitch Late potentials and the Brugada syndrome. , 2002, Journal of the American College of Cardiology.

[51]  G. Sideris,et al.  Overdose of cyclic antidepressants and the Brugada syndrome. , 2002, The New England journal of medicine.

[52]  A. García-Alberola,et al.  Brugada‐Like Electrocardiographic Pattern Induced by Fever , 2002, Pacing and clinical electrophysiology : PACE.

[53]  C. Antzelevitch Brugada syndrome: historical perspectives and observations. , 2002, European heart journal.

[54]  S. Priori,et al.  Natural History of Brugada Syndrome: Insights for Risk Stratification and Management , 2002, Circulation.

[55]  T. Símor,et al.  Haemopericardium and Brugada-like ECG pattern in rheumatoid arthritis , 2002, Heart.

[56]  M. Barmada,et al.  Clinical and Molecular Heterogeneity in the Brugada Syndrome: A Novel Gene Locus on Chromosome 3 , 2002, Circulation.

[57]  G. Breithardt,et al.  Cardiac Autonomic Dysfunction in Brugada Syndrome , 2002, Circulation.

[58]  J. Towbin,et al.  Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. , 2002, Human molecular genetics.

[59]  J. Towbin,et al.  Long-Term Follow-Up of Individuals With the Electrocardiographic Pattern of Right Bundle-Branch Block and ST-Segment Elevation in Precordial Leads V1 to V3 , 2002, Circulation.

[60]  W. Shimizu,et al.  Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. , 2002, Journal of the American College of Cardiology.

[61]  K Tungsanga,et al.  New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. , 2002, European heart journal.

[62]  W. Shimizu,et al.  Paradoxic Abbreviation of Repolarization in Epicardium of the Right Ventricular Outflow Tract During Augmentation of Brugada‐Type ST Segment Elevation , 2001, Journal of cardiovascular electrophysiology.

[63]  F. Cosío,et al.  Asymptomatic Brugada Syndrome Case Unmasked During Dimenhydrinate Infusion , 2001, Journal of cardiovascular electrophysiology.

[64]  J. Ortega-Carnicer,et al.  Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion. , 2001, Journal of electrocardiology.

[65]  T. Iwasaka,et al.  Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. , 2001, Journal of the American College of Cardiology.

[66]  A. Wilde,et al.  Quinidine Induced Electrocardiographic Normalization in Two Patients with Brugada Syndrome , 2001, Pacing and clinical electrophysiology : PACE.

[67]  H Imamura,et al.  Successful Prevention of Recurrent Ventricular Fibrillation by Intravenous Isoproterenol in a Patient with Brugada Syndrome , 2001, Pacing and clinical electrophysiology : PACE.

[68]  S. Kuribayashi,et al.  Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome. , 2001, European heart journal.

[69]  J. Balser,et al.  The cardiac sodium channel: gating function and molecular pharmacology. , 2001, Journal of molecular and cellular cardiology.

[70]  D. Corrado,et al.  Right Bundle Branch Block, Right Precordial ST-Segment Elevation, and Sudden Death in Young People , 2001, Circulation.

[71]  F. Morady,et al.  Brugada Syndrome Mimicked by Tricyclic Antidepressant Overdose , 2001, Journal of cardiovascular electrophysiology.

[72]  B. Schulte,et al.  Possible Role of Epicardial Left Ventricular Programmed Stimulation in Brugada Syndrome , 2001, Pacing and clinical electrophysiology : PACE.

[73]  C. Antzelevitch The Brugada Syndrome: Ionic Basis and Arrhythmia Mechanisms , 2001, Journal of cardiovascular electrophysiology.

[74]  P. Asfar,et al.  Transient ST Segment Elevation in Right Precordial Leads Induced by Psychotropic Drugs: Relationship to the Brugada Syndrome , 2001, Journal of cardiovascular electrophysiology.

[75]  R. Hauer,et al.  Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation. , 2000, European heart journal.

[76]  K. Sunagawa,et al.  Effect of Sodium Channel Blockers on ST Segment, QRS Duration, and Corrected QT Interval in Patients with Brugada Syndrome , 2000, Journal of cardiovascular electrophysiology.

[77]  S. Priori,et al.  Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome: A Prospective Evaluation of 52 Families , 2000, Circulation.

[78]  H. Kataoka Electrocardiographic patterns of the Brugada syndrome in right ventricular infarction/ischemia. , 2000, The American journal of cardiology.

[79]  H Suzuki,et al.  Infant Case with a Malignant Form of Brugada Syndrome , 2000, Journal of cardiovascular electrophysiology.

[80]  R. Svenson,et al.  Brugada-type electrocardiographic pattern induced by cocaine. , 2000, Mayo Clinic proceedings.

[81]  J L Rey,et al.  Prevalence of the brugada syndrome in an apparently healthy population. , 2000, The American journal of cardiology.

[82]  W. Shimizu,et al.  Body Surface Distribution and Response to Drugs of ST Segment Elevation in Brugada Syndrome: Clinical Implication of Eighty‐Seven–Lead Body Surface Potential Mapping and Its Application to Twelve‐Lead Electrocardiograms , 2000, Journal of cardiovascular electrophysiology.

[83]  D. Haines,et al.  Transient ST elevation after transthoracic cardioversion in patients with hemodynamically unstable ventricular tachyarrhythmia. , 2000, The American journal of cardiology.

[84]  J. Brugada,et al.  Arrhythmia Induction by Antiarrhythmic Drugs , 2000, Pacing and clinical electrophysiology : PACE.

[85]  L. Zaputović,et al.  Unmasking Effect of Propafenone on the Concealed Form of the Brugada Phenomenon , 2000, Pacing and clinical electrophysiology : PACE.

[86]  W. Shimizu,et al.  ST Segment and T Wave Alternans in a Patient with Brugada Syndrome , 2000, Pacing and clinical electrophysiology : PACE.

[87]  J. Towbin,et al.  Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. , 2000, Circulation.

[88]  G. Yan,et al.  Ventricular Fibrillation in a Patient with Prominent J (Osborn) Waves and ST Segment Elevation in the Inferior Electrocardiographic Leads: , 2000, Journal of cardiovascular electrophysiology.

[89]  A. Madrid,et al.  Fibrilación ventricular recurrente durante un proceso febril en un paciente con síndrome de Brugada , 2000 .

[90]  A. Hernández Madrid,et al.  [Recurrent ventricular fibrillation during a febrile illness in a patient with the Brugada syndrome]. , 2000, Revista espanola de cardiologia.

[91]  J. Brugada,et al.  Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden death. , 2000, Journal of electrocardiology.

[92]  A. Wilde,et al.  A single Na(+) channel mutation causing both long-QT and Brugada syndromes. , 1999, Circulation research.

[93]  C Antzelevitch,et al.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. , 1999, Circulation research.

[94]  C. Antzelevitch,et al.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. , 1999, Circulation.

[95]  S. Viskin,et al.  Effects of Electrophysiologic‐Guided Therapy with Class IA Antiarrhythmic Drugs on the Long‐Term Outcome of Patients with Idiopathic Ventricular Fibrillation with or without the Brugada Syndrome , 1999, Journal of cardiovascular electrophysiology.

[96]  J. Farré,et al.  Brugada‐Like Electrocardiographic Pattern in a Patient With a Mediastinal Tumor , 1999, Pacing and clinical electrophysiology : PACE.

[97]  H. Morita,et al.  Asymptomatic Form of Brugada Syndrome , 1999, Pacing and clinical electrophysiology : PACE.

[98]  J. Brugada,et al.  Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts. , 1999, The American journal of cardiology.

[99]  K Shimomura,et al.  The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. , 1999, European heart journal.

[100]  A. Wilde,et al.  "Brugada" syndrome: clinical data and suggested pathophysiological mechanism. , 1999, Circulation.

[101]  M. Gardner,et al.  Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. , 1998, Circulation.

[102]  M. Josephson,et al.  ST Segment Elevation Induced by Class IC Antiarrhythmic Agents: Underlying Electrophysiologic Mechanisms and Insights into Drug‐Induced Proarrhythmia , 1998, Journal of cardiovascular electrophysiology.

[103]  W. Shimizu,et al.  Dynamic Changes of 12‐Lead Electrocardiograms in a Patient with Brugada Syndrome , 1998, Journal of cardiovascular electrophysiology.

[104]  G. Breithardt,et al.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.

[105]  J. Brugada,et al.  Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. , 1998, Circulation.

[106]  K. Nademanee,et al.  Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. , 1997, Circulation.

[107]  H Kasanuki,et al.  Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. , 1997, Circulation.

[108]  Y. Aizawa,et al.  Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome. , 1997, Journal of electrocardiology.

[109]  R. Bolognesi,et al.  Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose. , 1997, The American journal of cardiology.

[110]  Y. Aizawa,et al.  Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. , 1996, Journal of the American College of Cardiology.

[111]  D. Corrado,et al.  Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. , 1996, Journal of the American College of Cardiology.

[112]  A. Proclemer,et al.  [Recurrent ventricular fibrillation, right bundle-branch block and persistent ST segment elevation in V1-V3: a new arrhythmia syndrome? A clinical case report]. , 1993, Giornale italiano di cardiologia.

[113]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[114]  P. Malasit,et al.  Pathogenesis of sudden unexplained nocturnal death (lai tai) and endemic distal renal tubular acidosis , 1991, The Lancet.

[115]  C Antzelevitch,et al.  Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. , 1990, Circulation research.

[116]  L. Horan,et al.  Electrocardiographic J wave of hypercalcemia. , 1984, The American journal of cardiology.

[117]  P. Douglas,et al.  Extreme hypercalcemia and electrocardiographic changes. , 1984, The American journal of cardiology.

[118]  E. Henze,et al.  Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. , 1984, Circulation.

[119]  G. Furst Sudden, unexpected, nocturnal deaths among Southeast Asian refugees. , 1982, MMWR. Morbidity and mortality weekly report.

[120]  D. Harrington,et al.  Experimentally induced thiamine deficiency in beagle dogs: clinical observations. , 1981, American journal of veterinary research.

[121]  M. Cheitlin,et al.  The nonspecific camel-hump sign. , 1976, JAMA.

[122]  C. Hersch,et al.  Electrocardiographic Changes in Head Injuries , 1961, Circulation.

[123]  J. Osborn Experimental hypothermia; respiratory and blood pH changes in relation to cardiac function. , 1953, The American journal of physiology.

[124]  W. Somerville,et al.  Clinical recognition and treatment of acute potassium intoxication. , 1950, Annals of internal medicine.

[125]  G. B. Myers Other QRS‐T Patterns that May Be Mistaken for Myocardial Infarction: IV. Alterations in Blood Potassium; Myocardial Ischemia; Subepicardial Myocarditis; Distortion Associated with Arrhythmias , 1950, Circulation.